HOME HEALTH MONITORING

Continuous “Resting” HR & RR monitoring Matters.

Any disease responsible for hypoxemia, hypocapnia or hypercapnia, such as pneumonia, pulmonary embolism, acute heart failure or acute exacerbation of COPD,will be detected quickly by a modification of RR. During acute respiratory failure, RR is the best marker of disease severity and prognosis. It is more relevant than pulse oximetryhttps://link.springer.com/article/10.1007/s10877-019-00357-1
image


Xandar Kardian XK300-H shown. CES 2022 Demo. Market Launch: Summer, 2022.

User manual: Sleep in your own bed.

Continuously, Consistently, Accurately, Reliably and Automatically monitor motion (actigraphy), resting heart rate and breathing rate through out day and night while simply being at home and sleeping in your own bed.

Focus: Patients with Chronic Respiratory and Cardiovascular Disease.

There are an estimated 92 million Americans that suffer from a form of CRD (Chronic Respiratory Disease) or CVD (Cardiovascular Disease). Some 15 million of them are seniors. Continuous monitoring of RHR + RR may provide important information in their treatment and also give early deterioration detection alerts.

Cardiovascular

71M Americans suffer from CVD. Home monitoring of HR can be a predictor of imminent cardiovascular events.

Learn more:  [1]
COPD

15.7M Americans are diagnosed with COPD. Continuous RR rises during acute exacerbations of COPD may be a promising predictor.

Learn more:  [1]
COVID19

About 10% of COVID-19 patients (4.2M Americans) become long haulers who may need life-long respiratory support and monitoring.

Learn more:  [1] [2] [3]
Pneumonia

Pneumonia is responsible for over 1.3M hospital visits per year in the US. RR is nearly always associated with it and may be the only indicator that something ominous is occurring.

Learn more:  [1]

FDA 510(K) CLEARED FOR HOME USE.

“Plug and Point” Design

The XK300-H is designed to be setup and used by anyone – no techy nephew or grandson needed! Simply plug in the power and the system will auto-calibrate on its own. On-board LTE-M will securely transmit valuable data to a HIPAA compliant server to be reviewed by a physician or clinician.


Xandar Kardian XK300-H shown. CES 2022 Demo. Market Launch: Summer, 2022.

image

THOUSANDS OF MEASUREMENTS EACH DAY

Powerful insight from accurate, consistent measurements.

Xandar Kardian’s XK300 sensor is able to detect vital signs 10 times per second giving 600 results per minute. During one 8 hour overnight period, if the user was “still” for 5 hours (out of 8 hours), we can estimate that 18,000 seconds of vital sign data was collected. Daily recording of motion, RHR and RR can provide critical insight to the residents overall health & wellbeing.
Users also have the option of assigning “caretakers” who can be friends, neighbors or family. Caretakers are given access to the users vital signs, including potential alerts for adverse events.

KARDIAN WORKS WITH YOU

Prevention and Detection.

Monitoring with the XK300 can benefit anyone who suffers from acute or chronic conditions (COPD, Pneumonia, CHF, Sepsis) where early detection of a change in vital signs could signal an exacerbation of illness.

Xandar Kardian’s XK300 works to detect and help prevent illness exacerbations. Prevention and early detection saves time, money, and lives.

100% REIMBURSED, MONTHLY.

Medicare / Medicaid Reimbursed.

Xandar Kardian XK300 is FDA 510(k) cleared to use as a home healthcare sensor for data collection to inform patient care. Certain users who have Medicaid/Medicare suffering from chronic respiratory diseases and CVDs can quality for Medicare/Medicaid reimbursement under CPT CODE 99454, 99457 and 99458.

Contact our sales
team

Find out how the XK300 will help when monitoring your condition.